BrainsGate

An implant that can improve blood flow to the brain in stroke patients will go before a US Food and Drug Administration advisory committee on 10 December, the agency has announced. The neurological de

Medtronic PLC has been one of the most acquisitive companies in recent years, clocking seven deals in 2014. And in spite of splashing a record $43 billion on Medtronic Minimally Invasive Therapies

Transport Technologies Delivering compounds across the blood-brain barrier remains the rate limiting step in brain-drug development, yet the problem generally gets ignored until it’s too late. Several

The field of stroke moves slowly; 17 years elapsed between the introduction of the thrombolytic drug tPA, the first FDA-approved intervention for acute ischemic stroke, and the clot retrieving device